Virus reduction neutralization test and LI-COR microneutralization assay bridging and WHO international standard calibration studies for respiratory syncytial virus

Bioanalysis. 2022 Aug;14(15):1067-1079. doi: 10.4155/bio-2022-0097. Epub 2022 Sep 20.

Abstract

Background: Respiratory syncytial virus (RSV) vaccine is an unmet medical need. The virus reduction neutralization test (VRNT) was developed to replace the LI-COR microneutralization assay to measure RSV neutralization titers. Methods: A bridging study using selected V171 phase I samples and calibration studies using the WHO international standard antiserum to RSV were performed to compare VRNT and LI-COR. Results: From the bridging study, we showed good concordance between VRNT and LI-COR titers, and similar post-/prevaccination titer ratios. From the calibration studies, we can convert VRNT and LI-COR titers into similar IU/ml. Conclusion: The VRNT and LI-COR microneutralization assay correlate well and the titers can be standardized as similar IU/ml, enabling direct comparison of titers from different assays.

Keywords: WHO international standard; bridging study; calibration study; microneutralization assay; respiratory syncytial virus; virus reduction neutralization test.

MeSH terms

  • Antibodies, Neutralizing
  • Calibration
  • Neutralization Tests
  • Respiratory Syncytial Viruses*
  • Vaccines*
  • World Health Organization

Substances

  • Antibodies, Neutralizing
  • Vaccines